Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma - Contacts and Locations

Home

Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma

This study is ongoing, but not recruiting participants.

Study NCT00027911. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00027911

Locations


United States, New York
	Herbert Irving Comprehensive Cancer Center at Columbia University
	New York, New York, United States, 10032

Sponsors and Collaborators

Herbert Irving Comprehensive Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Kyriakos P. Papadopoulos, MD	Herbert Irving Comprehensive Cancer Center